Stocks to Watch: Focus on Regulus Therapeutics Inc. (RGLS), Lilis Energy, Inc. (LLEX)

The price of Regulus Therapeutics Inc. (NASDAQ:RGLS) went up by $0.07 now trading at $1.3. Their shares witnessed a 62.5% increase from the 52-week low price of $0.8 they recorded on 2018-12-24. Even though it is still -721.54% behind the $10.68 high touched on 2018-03-14. The last few days have been good for the stock, as its price has grew by 17.49% during the week. It has also performed poorly over the past three months, as it lost around -11.56% while it has so far retreated around -88.2% during the course of a year. The stock of RGLS recorded 39.69% uptrend from the beginning of this year till date. The 12-month potential price target for Regulus Therapeutics Inc. is set at $3.17. This target means that the stock has an upside potential to increase by 143.85% from the current trading price.

When giving their opinion, around 0% of Wall Street analysts, which represents 0 out of 4 rated the stock as a Buy. 4 brokerage firms of the remaining 100% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate RGLS shares held by institutional investors represents 31.3% of total shares. 7 institutions entered new Regulus Therapeutics Inc. (NASDAQ:RGLS) positions, 11 added to their existing positions in these shares, 26 lowered their positions, and 14 exited their positions entirely.

Regulus Therapeutics Inc. (RGLS) trade volume has decreased by -61.39% as around 126,567 shares were sold when compared with its 50-day average volume of traded shares which is 327,842. At the moment, RGLS is witnessing a uptrend, as it is trading 16.67% above its 20-day SMA, 21.02% above its 50-day SMA, and -55.39% above its 200-day SMA. The company runs an ROE of roughly -311.5%, with financial analysts predicting that their earnings per share growth will be around 39.6% per annum for the next five year. This will be compared to the 25.9% increase witnessed over the past five years.

The first technical resistance point for Regulus Therapeutics Inc. (NASDAQ:RGLS) will likely come at $1.32, marking a 1.52% premium to the current level. The second resistance point is at $1.35, about 3.7% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $1.21, the lower end of the range. RGLS’s 14-day MACD is 0.05 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 64.71, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 82.12 percent, which is low when compared to that of the 50-day’s 94.56 percent.

The shares of Lilis Energy, Inc. (NYSE:LLEX) has increased by 4.08%, and now trading at $1.53 on the Wall Street in the intra-day deal, with their shares traded now around 680,958. This is a rise of 311,580 shares over the average 369,378 shares that were traded daily over the last three months. The stock that is trading at $1.53 went higher by 44.34% from its 52-week low of $1.06 that it attained back on 2018-12-27. The stock recorded a 52-week high of $6.3 nearly 288 days ago on 2018-05-30.

LLEX stock hasn’t performed well over the past 30 days, as it lost -15.47% while its price climbed by 11.68% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -12.57% over the last week. The stock’s 12-month potential target price is now at $4.15. This means that the stock price might likely increase by 171.24% from its current trading price.7 out of 10 Wall Street analysts which represents 70% rated the stock as a buy while the remaining 30% rated it as a hold, with 0% of analysts rating it as a sell.

Lilis Energy, Inc. (NYSE:LLEX) has been utilizing an ROE that is roughly 215.1%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the 46.3% raise that was witnessed during the past five years. The stock at the moment is on a downtrend, trading -17.27% below its 20-day SMA, -14.44% below its 50-day SMA, and -57.03% below its 200-day SMA. In percentage terms, the aggregate Lilis Energy, Inc. shares held by institutional investors is 0%. 15 institutions jumped in to acquire Lilis Energy, Inc. (LLEX) fresh stake, 31 added to their current holdings in these shares, 47 lowered their positions, and 19 left no stake in the company.

The stock’s 9-day MACD is -0.16 and this negative figure indicates a downward trading trend. The company’s 9-day RSI score is 32.56, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 77.01 percent, which is less when compared to that of the 50-day’s 96.14 percent. On the daily chart, we see that the stock could reach the first level of resistance at $1.58, sporting a 3.16% premium to the current level. The next resistance point is at $1.62, representing nearly 5.56% premium to the current market price of Lilis Energy, Inc. (LLEX). On the other hand, failure to breach the immediate hurdles can drag it down to $1.39, the lower end of the range.

error: Content is protected !!